Problems and Suggestions for Improving Surveillance System for Adverse Events Following Immunization in Songkhla
Article Sidebar
Main Article Content
Abstract
Objective: To study the surveillance system for Adverse Events Following Immunization (AEFI), problems in the system and suggestions for the development of AEFI surveillance system in Songkhla. Method: This study was qualitative research. The study collected the data from AEFI report, followed by in-depth interview with 19 staff members who were in charge of vaccine within related organizations at regional, provincial, district, and sub-district levels. Subsequently the researchers organized focus group discussion among 24 of those responsible for vaccines to identify problems in AEFI surveillance system and to collect the suggestions for improving the system in Songkhla.Results: The AEFI surveillance systems involved various organizations. However, coordination among them was not strong.There were seven problems in the AEFI surveillance systems including policy, work system, training, standard and handbook, authorities, parents, and reporting. Five most frequently mentioned problems included small numbers of AEFI reports (n=19), having inadequate knowledge on AEFI and types of AEFI with mandatory report (n=19), being fear of admonishment (n=19), not being a priority in the view of management (n=17), and incomplete report on vaccination and related detail (n=14). Suggestions for improving AEFI surveillance system were in 4 domains including policy, working system forAEFI surveillance, standard and handbook, and authority and training. Aspects of the AEFI surveillance system with Songkhla additional to the old one were screening of those with high risk of AEFI before vaccination, cards for informing of patient with suspected AEFI during treatment and dispensing, and encouraging of authorities to educate parents on AEFI and distributing AEFI report form to parents. Conclusion: There were seven domains of problems in AEFI surveillance systems. Collective effort is needed to improve the
Article Details
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
2. Prempree P, Tipparat K. Surveillance and investiga- tion of adverse events following immunization (AEFI). Bangkok: Bureau of Epidemiology, Depart ment of Disease Control, Ministry of Public Health; 2008. p.6-14.
3. Areechokchai A, Chantasiriyakorn S, Wongsawan P, Thepsittha K, Tonghong A, Sutthachana S, et al. Situations of measles mumps rubella of Thailand. In: Chantasiriyakorn S, editors. The summary of situations and knowledge from surveillance and investigation of adverse events following immuniza tion of MMR vaccines. Bangkok: Agricultural Coope rative Federation Printing of Thailand;2009. p.11-2.
4. Stratton KR, Howe CJ, Johnston RB. Adverse events associated with childhood vaccines: evidence bearing on causality. Washington DC: Division of Health Promotion and Disease Prevention, Institu- tion of Medicine;1994.
5. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Retraction in: Ileallym phoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637-41.
6. Akobeng AK, Thomas AG. Inflammatory bowel disease, autism, and the measles, mumps, and rubella vaccine. J Pediatr Gastroenterol Nutr 1999; 28: 351-2.
7. Alicino C, Merlano C, Zappettini S, Schiaffino S, Luna GD, Accardo C, et al. Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety. Hum Vaccin Immunother 2015; 11: 91–4.
8. Tipparat K. Adverse events following immunization surveillance. Annual Epidemiological Surveillance Report 2009; 134-44.
9. Tipparat K. Adverse events following immunization surveillance. Annual Epidemiological Surveillance Report 2011;117-22.
10. Tipparat K. Adverse events following immunization surveillance. Annual Epidemiological Surveillance Report 2012; 67-71.
11. Monteiro SAMG, Takano OA, Waldman EA. Surveil lance for adverse events after DTwP/Hib vaccination in Brazil: Sensitivity and factors associated with reporting. Vaccine 2010; 28: 3127-33.
12. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Deter minants of under-reporting of adverse drug reactions : A systematic review. Drug Safety 2009; 32: 19-31.
13. Hasford J, Goettler M, Munter KH, Mer-Oerlinghau sen B. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol 2002; 55: 945-50.
14.World Health Organization, Western Pacific Regional Office. Immunization safety surveillance: guidelines for managers of immunization programme on reporting and investigating adverse events following immunization. [online].1999 [cited Dec 9, 2013]. Available from: iris.wpro.who.int/handle/10665.1/12 993
15. Fritzell B. Detection of adverse events: what are the current sensitivity limits during clinical development? Vaccine 2002; 20: S47–8.
16. Niu MT, Erwin DE, Braun MM. Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination. Vaccine 2001; 19: 4627–34.
17. Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA et al.The Vaccine Adverse Event Reporting System (VAERS). Vaccine 1994; 12: 542–50.
18. Bentsi-Enchill A, Hardy M, Koch J, Duclos P. Adverse events temporally associated with vaccines -1992 Report. Can Commun Dis Rep 1995; 21: 117-28.
19. Vermeer-de-Bondt PE, Wesselo C, Dzaferagic A, Phaff TAJ. Adverse events following immunisation under the National Vaccination Programme of The Netherlands. Number V—Reports in 1998. [online] .1998 [cited Mar16, 2013]. Available from: www.rivm .nl/bibliotheek/rapporten/000001004.html.
20. Chen RT, Glasser JW, Rhodes PH, et al. Vaccine Safety Data link Project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics 1997; 99: 765–73.
21. Chen RT. Safety of vaccines. In: Plotkin SA, Morti mer EA, editors. Vaccines. Philadelphia: Saunders; 1999. p.1144–63.
22. Newport MJ, Conway SP. Experience of a specialist service for advice on childhood immunization. J Infect 1993; 26: 295–300.
23.Gold M, Goodwin H, Botham S, Burgess M, Nash M, Kempe A. Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunization service. Arch Dis Child 2000; 83: 128–31.
